valid by Harris et al. (1967) in a review of 202 patients with coeliac disease in Birmingham.
Malignancy, however, has not been confined to lymphoma. Thus the reports of the 15 patients with adenocarcinoma of the jejunum have been reviewed by Petreshock et al. (1975) , while Harris et al. (1967) found that the incidence ofgastrointestinal carcinoma was significantly increased, particularly oesophageal carcinoma in men.
Some doubt as to the primary nature of coeliac disease in the association with malignancy was expressed by Creamer (1964) . He suggested that malignancy in any part of the body might be associated with villous atrophy, though others in checking jejunal biopsies in patients with malignancy have failed to support this suggestion (Girdwood 1964; Fischer et al., 1965) . Nevertheless, Brunt et al. (1969) in reviewing small bowel tumours seen over a period of 10 years again raised the possibility that malignancy itself was the cause of the villous changes encountered in some patients. 'Widespread infiltration or destruction of bowel wall may also cause malabsorption but alteration of villous structure at sites outside the areas of the bowel affected by malignant disease could also lead to deranged function'. They suggested that 'either villous atrophy represents a fundamental change in mucosal stability associated with or predisposing to malignancy or that villous atrophy can be directly produced by malignancy'. also expressed some reservations concerning the significance of mucosal 612 group.bmj.com on April 3, 2017 -Published by http://gut.bmj.com/ Downloaded from changes when considering 18 patients in whom they had undertaken mucosal cell turnover studies and who had the characteristic biopsy findings of coeliac disease. The loss rate of DNA was significantly less in the 10 patients who responded poorly to a gluten-free diet, suggesting that they had a 'hypoplastic mucosa' and that the process by which the mucosal abnormality was produced might be different from that of uncomplicated coeliac disease-for example, malignancy which had developed in five of these patients. They pointed out, however, that patients who had responded to a gluten-free diet might later fail to respond to the diet and that therefore mucosal turnover studies might have important prognostic implications. However, no more of the 10 patients have as yet developed malignancy (Read, 1976) . also suggested that some patients with a flat biopsy might have developed this change as a result of infiltration of the mucosa by malignant cells and, by inference, that some patients presenting with lymphoma and a flat biopsy and the features of a malabsorption syndrome were not suffering from coeliac disease.
Criticism can be made of the series reported by Harris et al. (1967) Results By the end of 1975, the mean length of follow-up was 13-2 years, 7-4 years for those who had died and 18 years for those still living. Of the 20 further deaths during the last 10 years, 10 were due to malignant disease. The total number of deaths in the series was 97 of which 37 were due to cancer (Table 1) . Necropsies were performed in 78 Because the study covered a wide range of calendar years, cohort analysis was the method of choice. The Case-Pearson mortality tables were used as the basis for computing expected numbers of deaths (Case and Pearson, 1957) . For each sex, the quinary-quinquennial rates were interpolated between both age-year groupings to produce an array of rates specific for age and calendar year. By applying the rates to comparable person-years at risk-that is, the years of survival contributed by each member of the series at a specific age in a specified year-the number of deaths that might be expected to occur during the period was computed for all causes, all malignancies, carcinoma of the oesophagus, and carcinoma of the pharynx. Because the cohort rates for lymphoma were not available, the expectation for this condition were determined by applying an annual rate (based on 1965 deaths) over the whole period. The resultant expectations were compared with the observed mortality and the statistical significance of the difference between them was assessed by use of the Poisson distribution. (Table 3 ). Seven additional patients had group.bmj.com on April 3, 2017 -Published by http://gut.bmj.com/ Downloaded from Coeliac disease, gluten-free diet, and malignancy 615 developed tumours but were still alive at the time of 7-6 months and to carcinoma 8-3 months respecreview (Table 4) . Thirteen died of reticulum cell tively. Of the whole group of 21 patients dying with sarcoma at an average age at death of 53-9 years, malignancy, 13 had been treated with a gluten-free range 36-82 years (Table 5 ) and eight from carcinoma diet for a mean period of 41 months. All seven who mean age 53-7 years, range 36-71 years (Table 6) .
had been on a diet for longer than a year, mean 6-0 The duration of symptoms of coeliac disease years, experienced a satisfactory clinical response before the onset of symptoms attributed to lym-initially. The subsequent deterioration of their phoma averaged 26 years and the corresponding health was presumed to be due to malignant comfigure for carcinoma was 25-5 years. The mean plications. Of the six patients who had received a duration of symptoms attributed to lymphoma was gluten-free diet for less than 12 months, only one showed an adequate clinical response (for some purposes of data analysis these particular patients were grouped with those who had always taken a normal diet). The onset of malignancy was the event which led to the diagnosis of coeliac disease in seven patients, six with reticulum cell sarcoma (cases 59, 94, 105, 138, 139, 188) and case 86 with carcinoma of the stomach. Case 105 did not complain of any symptoms until nine months before death when they were considered to be due to malignant disease. A jejunal biopsy carried out six months before death was consistent with coeliac disease and necropsy performed within one hour of death revealed that the mucosa of the small intestine throughout the length was flat with deposits of reticulum cell sarcoma in the mesenteric lymph nodes and liver but none in the bowel itself. On the other hand, the other six patients in this group had had symptoms from between six and 36 years which could have been attributed to coeliac disease. For example, case 139 was treated at the Children's Hospital Birmingham as a coeliac and, although lost to follow-up until his final illness, stated that he had never felt really well and had been prone to gastrointestinal upsets. Case 188 had a macrocytic anaemia for 15 years: in addition, subsequent investigations of her relatives revealed a sister with coeliac disease that had previously been unsuspected.
When deaths from all malignancies were analysed irrespective of the diet that was taken a statistically significant increase occurred in deaths from cancer both in the whole series and in men and women separately (Table 7 ). An increase was noted in Patients taking a normal diet were at greater risk of developing a malignant tumour than the population as a whole (p < 005) (Table 8) . However, seven tumours occurred in those patients on a gluten-free diet, a figure significantly in excess of that expected, all in subjects who had shown a good clinical response. Deaths from reticulum cell sarcoma both in those on a normal diet and in those on a gluten-free diet were also significantly increased. No deaths from either carcinoma or reticulum cell sarcoma were encountered in patients who had shown a suboptimal response to gluten withdrawal. Furthermore, of the six patients who had been treated for an average of 11 years with a gluten-free diet and who had shown good clinical response but whose jejunal morphology had not improved, none developed malignancy. A further analysis of data was carried out in which all patients who had been treated with a gluten-free diet for longer than 12 months were considered together irrespective of their clinical response. Those individuals who had taken the diet for less than 12 months were grouped with those patients who had been having a conventional diet (Table 9 ). In both groups there was an excess of deaths from all malignancies and lymphomas when compared with the general population. In the Figure series I there has been an increase in deaths from cancer, particularly reticulum cell sarcoma and gastrointestinal cancer.
To remove any doubt as to whether those patients who had not undergone jejunal biopsy in the earlier series (series I) biased the statistics on the incidence of malignancy, an analysis of all patients with coeliac disease proven by biopsy up to the end of 1972, and followed up on the unit, was undertaken (series II). The date of diagnosis by jejunal biopsy, which represents a precise event, was taken as the date of entry into the series and from which the period of observation was measured. To extend the analysis backward in time to the date of first symptoms, for example, would introduce an element of bias for two reasons; first, it is often impossible to obtain accurate information from patients of events occurring several years before clinical diagnosis and secondly, and perhaps more important, the series represents a selected sample in that all patients are alive at the date of diagnosis. Thus, expected deaths computed for a 'symptomatic' period could never be matched by observation.The analysis confirmed that there is a significantly increased risk of malignancy in coeliac disease and, in this group, malignancy was the cause of 21 of the 43 deaths encountered.
Again, the incidence of lymphoma, in particular reticulum cell sarcoma, was increased. Though no further oesophageal cancers had been seen since the publication of the earlier series (series I) and only two of the original six had been biopsied, the incidence was still significantly increased. Two patients with carcinoma of the pharynx provided further evidence of the liability of the upper gastrointestinal tract to develop malignancy. The association noted between the Epstein-Barr virus and nasopharyngeal carcinoma is of interest in this [ (Epstein, 1970; Klein, 1971) , suggesting the possibility that oncogenic viruses might play a part in the occurrence of this tumour in coeliac disease. No patients in this series developed carcinoma of the duodenum, but two were seen in consultation in the hospital, one who had been on a gluten-free diet for five years and the other presenting as intestinal obstruction.
Consideration must be given to those patients who presented with malignancy, had a flat biopsy, and died within a short period as to whether they can be included as having coeliac disease or whether the flat mucosa represents the response to malignancy, as postulated by Brunt et al. (1969) and . Only one of the seven patients in this category had a relatively short history; the other six had long histories compatible with coeliac disease as long as 36 years and averaging 21 2 years, even though it was the onset of malignant disease that brought them to diagnosis. The occufrence of asymptomatic patients with flat biopsies is now established. In a survey of first degree relatives of coeliac patients 11 % were discovered to have the characteristic jejunal biopsy and one-third of these were without symptoms (Stokes et al., 1976) . The lack of any appreciable incidence of flat biopsies among patients with carcinoma (Girdwood, 1964; Fu and Perzin, 1972; Gilat et al., 1973) does not support the suggestion that cancer can be responsible for the appearance of the jejunal biopsy. Thus, Petreshock et al. (1975) in reporting the occurrence of carcinoma of the jejunum in a patient who had been successfully treated for 13 years on a gluten-free diet pointed out that the majority of the 15 patients reported with this complication had a long history, usually of more than 30 years. It is also pertinent that three of our patients on a gluten-free diet had shown virtually complete histological remission in their jejunal biopsies at the time that their malignancy made its appearance, two with reticulum cell sarcoma (Cooke et al., 1969) and one with acute myeloid leukaemia, while at least three of those who came to necropsy showed a virtual absence of flat mucosa when the whole length of the small intestine was examined under the dissecting microscope and then randomly sectioned. However, since a flat mucosa can be produced in dermatitis herpetiformis (which has a close association with coeliac disease) by feeding gluten (Weinstein, 1974) , the possibility that the metabolic derangements of malignancy may be the necessary factor to produce flat biopsies in patients who already bear the coeliac trait albeit not having until then the characteristic biopsy cannot be ruled out. It is our present view that patients presenting with malignancy and with findings compatible with coeliac disease should be accepted as having coeliac disease which has been complicated by malignancy.
When considering the effect of a particular treatment in patients with a relatively rare chronic disease, sufficient numbers for analysis must be gathered over many years and observed for a long period of time for adequate assessment. Thus, for historical and indeed ethical reasons, the series could not be randomised with respect to diet and caution must therefore be exercised in evaluating the results of gluten withdrawal. Thus, person-years at risk rather than individuals have been allocated to categories of diet. Thus, a patient who remained on a normal diet for some years after diagnosis before receiving a gluten-free diet contributes the relevant 'years at risk' to each group; a patient must be alive to be considered for entry to the gluten-free diet group. Any deaths computed for the period between diagnosis and the start of gluten-free therapy could not be matched by observation.
The majority of patients with coeliac disease show dramatic improvement in all respects when placed on a gluten-free diet. It may therefore be asked whether they are also protected from developing malignancy. Austad et al. (1967) suggested that lymphoid hyperactivity in the jejunal mucosa of patients with coeliac disease may give rise to an increased incidence of malignancy, presumably on the grounds that the more mitoses occurring the greater the chance of mutant cells arising. It is also pertinent that there is a significant reduction of cells after gluten withdrawal (Holmes et al., 1974) , which might suggest therefore a lessened risk of malignancy. Furthermore, carcinogens (Wattenberg, 1966) might be more easily detoxicated by the coeliac mucosa and its enzymes when restored to normality by a gluten-free diet. There is no evidence in our present data to suggest that those with a poor response to a gluten-free diet are more liable to develop malignant complications as has been suggested by . However, epithelial cell turnover studies were not carried out, so that the patients in this series with a poor response may not be strictly comparable with those reported by .
This study has not provided evidence that a glutenfree diet is effective in preventing malignant complications. It is perhaps optimistic to expect to demonstrate any significant effect of a gluten-free diet in patients who have already been exposed to an oncogenic stimulus for many years, probably since birth. It is possible that for patients with coeliac disease their life experience before gluten withdrawat may have already determined their ultimate fatel Furthermore, while a gluten-free diet may preven. malignant complications in some of the younger patients and even prolong their lives, the histogram of all the deaths shows that patients with malignancy on the whole are dying in the same age range as those who are dying of other causes. Thus, a gluten-free diet may not materially prolong life but may alter the cause of death. While the evidence for coeliac disease harbouring malignant potential is undoubtedly very strong, it will be some years before it will be possible to provide evidence that a glutenfree diet decreases this risk or increases the expectation of life. At present to achieve this, one might speculate that such protection will necessitate lifelong abstinence from gluten. It may be that if a glutenfree diet does offer any protection against malignancy it will become apparant only in an analysis of a large group of patients who have been on diet since childhood. 
